Pain Management After Transnasal Transsphenoidal Surgery for Pituitary Adenomas
Status:
Recruiting
Trial end date:
2021-10-01
Target enrollment:
Participant gender:
Summary
We hypothesize that the effects of non-steroidal anti-inflammatory drugs (NSAIDS) for pain
relief among patients with pituitary adenomas undergoing transnasal transsphenoidal surgeries
are non-inferior to tramadol. We aim to launch a single-center randomized clinical trial to
verify this hypothesis.